Suppression of c‑FLIPL promotes JNK activation in malignant melanoma cells

Tian,Fen; Hu,Yange; Sun,Xixi; Lu,Gaihui; Li,Yan; Yang,Jing; Tao,Juan

doi:10.3892/mmr.2016.4856

Suppression of c‑FLIPL promotes JNK activation in malignant melanoma cells

Authors:
- Fen Tian
- Yange Hu
- Xixi Sun
- Gaihui Lu
- Yan Li
- Jing Yang
- Juan Tao
View Affiliations

Affiliations: Department of Dermatology, Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan 450015, P.R. China, Department of Dermatology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: February 3, 2016 https://doi.org/10.3892/mmr.2016.4856
Pages: 2904-2908

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The up‑regulation of cellular Fas‑associated death domain‑like interleukin‑1β‑converting enzyme (FLICE)‑like inhibitory protein (c‑FLIP) has been reported in various tumor types, and has been previously shown to be associated with the clinicopathological features of melanoma. To assess its potential role in cancer therapy, the present study evaluated the effects of short hairpin (sh)RNAs of different c‑FLIP isoforms on cellular proliferation and c‑Jun N‑terminal kinase (JNK) signaling. Human c‑FLIP shRNA plasmids were constructed and transfected into the A875 melanoma cell line. It was observed that c‑FLIP shRNA exhibited strong inhibitory effects against the levels of phosphorylated‑JNK and inhibited cellular proliferation in A875 cells. Thus, this indicated that c‑FLIP long form shRNA serves a specific inhibitory role in cellular proliferation through inducing the activation of the JNK pathway in A875 cells. The present study provided insight into the development of RNAi based therapies for melanoma.

View Figures

View References

1	Miller AJ and Mihm MC Jr: Melanoma. N Engl J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
2	Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol. 3:221–227. 2002. View Article : Google Scholar : PubMed/NCBI
3	Kamata H, Honda S, Maeda S, Chang L, Hirata H and Karin M: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649–661. 2005. View Article : Google Scholar : PubMed/NCBI
4	Kataoka T: The caspase-8 modulator c-FLIP. Crit Rev Immunol. 25:31–58. 2005. View Article : Google Scholar : PubMed/NCBI
5	Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME and Yang X: c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21:3704–3714. 2002. View Article : Google Scholar : PubMed/NCBI
6	Safa AR: c-FLIP, a master anti-apoptotic regulator. Exp Oncol. 34:176–184. 2012.PubMed/NCBI
7	Safa AR and Pollok KE: Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers (Basel). 3:1639–1671. 2011. View Article : Google Scholar
8	Wall NR and Shi Y: Small RNA: Can RNA interference be exploited for therapy? Lancet. 362:1401–1403. 2003. View Article : Google Scholar : PubMed/NCBI
9	Medarova Z, Pham W, Farrar C, Petkova V and Moore A: In vivo imaging of siRNA delivery and silencing in tumors. Nat Med. 13:372–377. 2007. View Article : Google Scholar : PubMed/NCBI
10	Shen HL, Xu W, Wu ZY, Zhou LL, Qin RJ and Tang HR: Vector-based RNAi approach to isoform-specific down-regulation of vascular endothelial growth factor (VEGF) 165 expression in human leukemia cells. Leuk Res. 31:515–521. 2007. View Article : Google Scholar
11	Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T and Nakano H: NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22:3898–3909. 2003. View Article : Google Scholar : PubMed/NCBI
12	Tian F, Lu JJ, Wang L, Li L, Yang J, Li Y, Liu YQ, Shen GX, Tu YT and Tao J: Expression of c-FLIP in malignant melanoma and its relationship with the clinicopathological features of the disease. Clin Exp Dermatol. 37:259–265. 2012. View Article : Google Scholar
13	Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y and Fujimoto K: Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer. Surgery. 138:71–77. 2005. View Article : Google Scholar : PubMed/NCBI
14	Dutton A, O'Neil JD, Milner AE, Reynolds GM, Starczynski J, Crocker J, Young LS and Murray PG: Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death. Proc Natl Acad Sci USA. 101:6611–6616. 2004. View Article : Google Scholar : PubMed/NCBI
15	Abedini MR, Qiu Q, Yan X and Tsang BK: Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro. Oncogene. 23:6997–7004. 2004. View Article : Google Scholar : PubMed/NCBI
16	Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, et al: CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Clin Cancer Res. 10:5202–5214. 2004. View Article : Google Scholar : PubMed/NCBI
17	Safa AR: Roles of c-FLIP in apoptosis, necroptosis, and autophagy. J Carcinog Mutagen. (Suppl 6): 0032013.PubMed/NCBI
18	Goldar S, Khaniani MS, Derakhshan SM and Baradaran B: Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev. 16:2129–2144. 2015. View Article : Google Scholar : PubMed/NCBI
19	Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
20	Weston CR and Davis RJ: The JNK signal transduction pathway. Curr Opin Cell Biol. 19:142–149. 2007. View Article : Google Scholar : PubMed/NCBI
21	Bubici C and Papa S: JNK signalling in cancer: In need of new, smarter therapeutic targets. Br J Pharmacol. 171:24–37. 2014. View Article : Google Scholar :
22	Uzdensky AB, Demyanenko SV and Bibov MY: Signal transduction in human cutaneous melanoma and target drugs. Curr Cancer Drug Targets. 13:843–866. 2013. View Article : Google Scholar : PubMed/NCBI
23	Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
24	Jørgensen K, Davidson B and Flørenes VA: Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Mod Pathol. 19:1446–1455. 2006.PubMed/NCBI
25	Day TW, Huang S and Safa AR: C-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8- and caspase-9-dependent apoptosis in breast cancer cells. Biochem Pharmacol. 76:1694–1704. 2008. View Article : Google Scholar : PubMed/NCBI
26	Sharp DA, Lawrence DA and Ashkenazi A: Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem. 280:19401–19409. 2005. View Article : Google Scholar : PubMed/NCBI
27	Wilson TR, McLaughlin KM, McEwan M, Sakai H, Rogers KM, Redmond KM, Johnston PG and Longley DB: C-FLIP: A key regulator of colorectal cancer cell death. Cancer Res. 67:5754–5762. 2007. View Article : Google Scholar : PubMed/NCBI
28	Wilson C, Wilson T, Johnston PG, Longley DB and Waugh DJ: Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells. Mol Cancer Ther. 7:2649–2661. 2008. View Article : Google Scholar : PubMed/NCBI
29	Park D, Shim E, Kim Y, Kim YM, Lee H, Choe J, Kang D, Lee YS and Jeoung D: C-FLIP promotes the motility of cancer cells by activating FAK and ERK and increasing MMP-9 expression. Mol Cells. 25:184–195. 2008.PubMed/NCBI
30	Naito M, Katayama R, Ishioka T, Suga A, Takubo K, Nanjo M, Hashimoto C, Taira M, Takada S, Takada R, et al: Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling. Mol Cell Biol. 24:8418–8427. 2004. View Article : Google Scholar : PubMed/NCBI
31	Shimada K, Nakamura M, Ishida E, Kishi M, Matsuyoshi S and Konishi N: The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells. Mol Carcinog. 39:1–9. 2004. View Article : Google Scholar
32	Wang W, Wang S, Song X, Sima N, Xu X, Luo A, Chen G, Deng D, Xu Q, Meng L, et al: The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis. Gynecol Oncol. 105:571–577. 2007. View Article : Google Scholar : PubMed/NCBI
33	Chen HX, Liu YJ, Zhou XD and Luo RY: Expression of cellular FLICE/caspase-8 inhibitory protein is associated with malignant potential in endometrial carcinoma. Int J Gynecol Cancer. 15:663–670. 2005. View Article : Google Scholar : PubMed/NCBI
34	Nakajima A, Komazawa-Sakon S, Takekawa M, Sasazuki T, Yeh WC, Yagita H, Okumura K and Nakano H: An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 25:5549–5559. 2006. View Article : Google Scholar : PubMed/NCBI
35	Nakajima A, Kojima Y, Nakayama M, Yagita H, Okumura K and Nakano H: Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Oncogene. 27:76–84. 2008. View Article : Google Scholar